Chronic obstructive pulmonary disease (COPD) affects approximately 29 million people in the U.S. and is the fourth leading ...
Dublin, Aug. 27, 2020 (GLOBE NEWSWIRE) -- The "Mucus Clearance Devices Market - Growth, Trends, and Forecast (2020 - 2025)" report has been added to ResearchAndMarkets.com's offering. The Mucus ...
Adjunctive therapy with a positive expiratory pressure (PEP) device may possibly decrease the length of hospital stays for patients with acute exacerbation of chronic obstructive pulmonary disease ...
CHAPEL HILL, N.C. & MIAMI--(BUSINESS WIRE)--Renovion and the COPD Foundation have announced the creation of a new partnership to accelerate the development of a novel therapy for the treatment of ...
CHAPEL HILL, N.C. & MIAMI--(BUSINESS WIRE)--Renovion and COPD Foundation Joint Release – Renovion, Inc. has announced that the first patient has been enrolled in a Phase 2 clinical study evaluating ...
An easy-to-use device developed by a local biomedical company is providing relief to Buffalo-area patients suffering from chronic obstructive pulmonary disease (COPD), which includes chronic ...
NORTH PHILADELPHIA (WPVI) -- Chronic obstructive pulmonary disease, better known as COPD, is a growing medical problem that literally takes your breath away. A possible treatment for one form of COPD ...
On March 15, the U.S. Food and Drug Administration (FDA) approved the first over-the-counter inhaler designed to help treat both chronic obstructive pulmonary disease (COPD) and asthma for patients ...
PHOENIX, Feb. 14 – Two devices that help clear secretions from the lungs can improve the respiratory health of hospitalized stroke patients, researchers reported today at the American Stroke ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback